Summit Therapeutics plc (SMMT): Price and Financial Metrics
SMMT Price/Volume Stats
| Current price | $17.87 | 52-week high | $33.89 |
| Prev. close | $18.40 | 52-week low | $2.10 |
| Day low | $17.71 | Volume | 7,099,100 |
| Day high | $18.60 | Avg. volume | 3,443,133 |
| 50-day MA | $19.53 | Dividend yield | N/A |
| 200-day MA | $12.13 | Market Cap | 13.18B |
SMMT Stock Price Chart Interactive Chart >
Summit Therapeutics plc (SMMT) Company Bio
Summit Therapeutics plc operates as a biopharmaceutical company primarily in the United Kingdom and the Unites States. It focuses on the discovery, development, and commercialization of novel medicines to treat the Duchenne Muscular Dystrophy (DMD), a fatal muscle wasting disease; and infections caused by Clostridium difficile bacteria (CDI). The company was founded in 2003 and is based in Abingdon, England.
SMMT Price Returns
| 1-mo | -5.95% |
| 3-mo | -18.44% |
| 6-mo | 123.10% |
| 1-year | 654.01% |
| 3-year | 489.77% |
| 5-year | 1,132.41% |
| YTD | 584.67% |
| 2023 | -38.59% |
| 2022 | 57.99% |
| 2021 | -42.77% |
| 2020 | 193.75% |
| 2019 | 39.13% |
Continue Researching SMMT
Here are a few links from around the web to help you further your research on Summit Therapeutics plc's stock as an investment opportunity:Summit Therapeutics plc (SMMT) Stock Price | Nasdaq
Summit Therapeutics plc (SMMT) Stock Quote, History and News - Yahoo Finance
Summit Therapeutics plc (SMMT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...